MORE DISAPPOINTMENT: Two major studies of an experimental Alzheimer’s drug show it doesn’t stop mental decline, the latest setback in finding a treatment for the mind-robbing disease.
HOPEFUL SIGN: There was a hint that the drug bapineuzumab, made by Pfizer Inc. and Johnson & Johnson, might help if given sooner, before the disease has caused too much damage and memory loss.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.